The opioid addiction crisis gripping the U.S. is currently one of the biggest health issues plaguing the country. In many cases, opioid addicts turn to using heroin or methamphetamine in order to get high. In what could potentially be the biggest medical breakthrough of the decade, scientists have reportedly developed a method to simply alter the DNA of addicts to help them overcome their vice.
The new treatment was developed by the University of Arkansas for Medical Sciences researchers, which involves inserting a genetically engineered gene into the DNA of a meth addict. This gene will then signal the body to create antibodies that will go after the drug, Futurism reports.
The delivery method of this treatment is via a virus and once it’s inside the patient, it will start making the changes. The resulting antibodies will bind with the meth molecules, thus preventing them from reaching the brain. While it won’t entirely eliminate the high that the addict experiences, it won’t be as pronounced as it would have been otherwise, no matter the dose.
With this new method, addicts can have a much easier time kicking the habit, especially when paired with behavioral therapies. Overcoming addiction is part psychological and part physical, after all, which can be particularly troublesome for patients who have terrible histories.
On that note, it’s worth pointing out that even with the gene therapy option, drug addicts could still fall into their old habits. What’s more, there’s the chance of meth addicts simply giving themselves higher doses to feel a stronger effect, MIT’s Technology Review recently reported.
The bottom line is that there is much more work to be done before drug addiction can be addressed using other drugs or even through gene therapy. However, it’s at least encouraging that there could be a future when addicts of all kinds can simply be cured with a simple shot in the arm.


Tabletop particle accelerator could transform medicine and materials science
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Neuralink Expands Brain Implant Trials with 12 Global Patients
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



